148 related articles for article (PubMed ID: 16473016)
1. Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.
Lai MK; Tsang SW; Garcia-Alloza M; Minger SL; Nicoll JA; Esiri MM; Wong PT; Chen CP; Ramírez MJ; Francis PT
Neurobiol Dis; 2006 Jun; 22(3):555-61. PubMed ID: 16473016
[TBL] [Abstract][Full Text] [Related]
2. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
[TBL] [Abstract][Full Text] [Related]
4. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
5. ApoE-epsilon 4-dependent association of the choline acetyltransferase gene polymorphisms (2384G>A and 1882G>A) with Alzheimer's disease.
Ahn Jo S; Ahn K; Kim JH; Kang BH; Kim E; Jo I; Kim DK
Clin Chim Acta; 2006 Jun; 368(1-2):179-82. PubMed ID: 16480703
[TBL] [Abstract][Full Text] [Related]
6. Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4.
Kim KW; Suh YJ; Park WY; Jhoo JH; Lee DY; Youn JC; Lee KH; Seo JS; Woo JI
Neurosci Lett; 2004 Aug; 366(2):182-6. PubMed ID: 15276243
[TBL] [Abstract][Full Text] [Related]
7. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
[TBL] [Abstract][Full Text] [Related]
8. [Study of relationship between ApoE epsilon4 allele and hippocampal atrophy in Alzheimer disease].
Li J; Kuang WH; Li J; Wang X; Huang MS; Wu DP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):50-2. PubMed ID: 15702779
[TBL] [Abstract][Full Text] [Related]
9. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls.
Kramer G; van der Flier WM; de Langen C; Blankenstein MA; Scheltens P; Stam CJ
Clin Neurophysiol; 2008 Dec; 119(12):2727-32. PubMed ID: 18848805
[TBL] [Abstract][Full Text] [Related]
10. Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism.
Kamruecha W; Chansirikarnjana S; Nimkulrat E; Udommongkol C; Wongmek W; Thangnipon W
Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):793-7. PubMed ID: 17121308
[TBL] [Abstract][Full Text] [Related]
11. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease.
Basso M; Gelernter J; Yang J; MacAvoy MG; Varma P; Bronen RA; van Dyck CH
Neurobiol Aging; 2006 Oct; 27(10):1416-24. PubMed ID: 16182410
[TBL] [Abstract][Full Text] [Related]
13. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease.
Corey-Bloom J; Tiraboschi P; Hansen LA; Alford M; Schoos B; Sabbagh MN; Masliah E; Thal LJ
Neurology; 2000 Jan; 54(2):403-6. PubMed ID: 10668702
[TBL] [Abstract][Full Text] [Related]
14. Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.
Darreh-Shori T; Brimijoin S; Kadir A; Almkvist O; Nordberg A
Neurobiol Dis; 2006 Nov; 24(2):326-33. PubMed ID: 16973370
[TBL] [Abstract][Full Text] [Related]
15. Does apolipoprotein E (Apo-E) genotype influence nicotinic receptor binding in Alzheimer's disease.
Reid RT; Sabbagh MN; Thal LJ
J Neural Transm (Vienna); 2001; 108(8-9):1043-50. PubMed ID: 11716140
[TBL] [Abstract][Full Text] [Related]
16. Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.
Tannenberg RK; Scott HL; Tannenberg AE; Dodd PR
Neurochem Int; 2006 Dec; 49(7):631-9. PubMed ID: 16814428
[TBL] [Abstract][Full Text] [Related]
17. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
Mufson EJ; Jaffar S; Levey AI
J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
[TBL] [Abstract][Full Text] [Related]
18. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M
Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246
[TBL] [Abstract][Full Text] [Related]
19. Premorbid effects of APOE on synaptic proteins in human temporal neocortex.
Love S; Siew LK; Dawbarn D; Wilcock GK; Ben-Shlomo Y; Allen SJ
Neurobiol Aging; 2006 Jun; 27(6):797-803. PubMed ID: 15979210
[TBL] [Abstract][Full Text] [Related]
20. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
